trofosfamide has been researched along with Experimental Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boos, J; Hempel, G; Wagner, A | 1 |
| Budzyński, W; Kinas, R; Kuśnierczyk, H; Misiura, K; Paprocka, M; Radzikowski, C; Rak, J; Stec, W | 1 |
1 review(s) available for trofosfamide and Experimental Neoplasms
| Article | Year |
|---|---|
Trofosfamide: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the oral treatment of cancer.
Topics: Administration, Oral; Animals; Antineoplastic Agents, Alkylating; Cyclophosphamide; Humans; Neoplasms; Neoplasms, Experimental | 1997 |
1 other study(ies) available for trofosfamide and Experimental Neoplasms
| Article | Year |
|---|---|
Antitumor activity of optical isomers of cyclophosphamide, ifosfamide and trofosfamide as compared to clinically used racemates.
Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Drug Evaluation, Preclinical; Female; Ifosfamide; Lethal Dose 50; Leukemia, Experimental; Lung Neoplasms; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Plasmacytoma; Stereoisomerism | 1986 |